Approval · Notice of Compliance 18832 · 2017
FINASTERIDE: Notice of Compliance 18832
Issued January 5, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18832
- Date
- January 5, 2017
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Update to product monograph to be in line with crp
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FINASTERIDE | 02350270 | Marketed |
Medicinal ingredients
- FINASTERIDE 5 MG per TAB